Authors



Richard Vuu, PharmD Candidate

Latest:

Insulin Pump Therapy and Continuous Glucose Monitoring

Insulin pump therapy and continuous glucose monitoring systems can be invaluable tools for patients with type 1 and type 2 diabetes.


Jeff T. White, PharmD, MS

Latest:

Analyzing the Impact of Different Value-Based Insurance Design Programs

Total 1-year healthcare costs were not significantly reduced by 2 value-based insurance design programs for diabetic patients, although education appeared to improve quality of care.


Philip P. Gerbino, PharmD

Latest:

Impact of Initial Days' Supply of Angiotensin II Receptor Blockers

For ARB-class antihypertensive agents, we examined the association among initial prescription supply days (ie, 30- or 90-day) and adherence, hospitalization risk, and healthcare use.


Alternate Care Sales for Specialty Pharmaceutical Distribution at Cardinal Health

Latest:

Uncovering Hidden Savings in the Hospital Pharmacy

The shift from fee-based, volume-driven care to value-based, patient-centered care and the growth of specialty pharmaceuticals are propelling us all into uncharted territory, no matter what role you play in health care.


Tao He, MS

Latest:

Effectiveness and Costs of Biologics in Veterans With Rheumatoid Arthritis

This study applied a validated algorithm to estimate the effectiveness and costs of the index biologic used by 4696 US veterans with rheumatoid arthritis.


Hoytin T. Lee Ghin, BSPharm, PharmD, BCPS

Latest:

Overactive Bladder Disease: Overcoming the Urge to Go

When discussing overactive bladder disease with a patient, the pharmacist needs to be sensitive to this treatable but often embarrassing medical condition.


Brian C. Sauer, PhD

Latest:

Effectiveness and Costs of Biologics in Veterans With Rheumatoid Arthritis

This study applied a validated algorithm to estimate the effectiveness and costs of the index biologic used by 4696 US veterans with rheumatoid arthritis.


Stella Quenstedt, MA

Latest:

Offer Patients Counseling on ADFs

Pharmacists can extend education to prescribers and provide important guidance on abuse-deterrent opioid formulations.



Dana A. Brown, PharmD, BCPS

Latest:

Natural Products on Deck: Keeping Joints in the Game

Many patients with osteoarthritis turn to complementary and alternative medicine, either as an adjunct to prescription therapy or to avoid side effects.


Jack J. Chen, PharmD, BCPS, BCGP, FASCP, FCCP

Latest:

Parkinson's Disease Psychosis: A Pharmacist's Update of New Treatment Options

This Continuing Education activity is supported by an educational grant from Acadia Pharmaceuticals Inc.


Steven R. Peskin, MD, MBA, FACP

Latest:

Opioid-Induced Constipation: Considerations for Formulary Decision Makers

This activity reviews the incidence and impact of opioid-induced constipation (OIC), discusses available treatment options, and what factors should be considered during formulary decisions for OIC.


Kevin Hirsch, MD

Latest:

Drivers of Change in Pharmacy Benefit Management

Executive-level pharmacy leaders in US managed care organizations identify how healthcare reform is driving changes in pharmacy benefit management.


Michelle Byrne, PharmD, MSPBA

Latest:

Ivosidenib for Relapsed/Refractory Acute Myeloid Leukemia

On July 20, 2018, the FDA approved ivosidenib (Tibsovo) as a treatment option for adult patients with relapsed/refractory acute myeloid leukemia, specifically with a mutation in the IDH1 gene.


Aaron Wang, PharmD candidate

Latest:

Addressing HIV with Incarcerated Individuals Requires Understanding of PrEP

The prevalence of HIV in jails and prisons is approximately 4 times higher than that of the general United States population.


Robert Lee Page II, PharmD, FCCP, FAHA, BCPS, CGP

Latest:

Pharmacist Expert Adviser

Women with Hypertension Face Unique Challenges



Jarah Yates, PharmD candidate

Latest:

HIV/AIDS: Curbing the Epidemic

Medications enable the management of HIV.


Glenn Schulman, PharmD

Latest:

Geriatric Cancers Present Many Therapeutic Challenges

Pharmacists should develop treatment plans with an active interdisciplinary team and patient involvement.



Daniel L. Krinsky, MS, RPh

Latest:

Improving Asthma Management with Tools and Devices

This Continuing Education activity is supported by an educational grant from Philips Respironics, Inc.


Christina Mattina

Latest:

Current and Future Status of Drug Pricing Reform as the Blueprint Approaches the 1-Year Mark

Several efforts are underway nearly a year after the Trump administration released its blueprint to lower drug prices in May 2018, but tracking their outcomes depends on what metric is used to define drug prices, according to a session at the Academy of Managed Care Pharmacy Managed Care & Specialty Pharmacy Annual Meeting, held March 25-28 in San Diego, California.


Jerry McKee, PharmD, MS, BCPP

Latest:

Mental Health First Aid as a Skill Set for Community Pharmacy Personnel

Mental illness affects tens of millions of people in the United States each year. However, overall, only about half of those affected receive treatment.


Kellie J. Ryan, MPH

Latest:

Cost-Effectiveness of Live Attenuated Versus Inactivated Influenza Vaccine Among Children

Vaccination with trivalent live attenuated versus inactivated influenza vaccine in children aged 2 to 17 years is cost saving or cost-effective depending on the severity of the influenza season.


By Con Lane

Latest:

Expand Your Pharmacy Footprint

With national brand recognition and expert support, pharmacy franchise owners reach more patients.



Dan-Andrei Waitman, MD, MPH

Latest:

Large-Scale, Community-Based Trial of a Personalized Drug-Related Problem Rectification System

A controlled trial of a system for rectifying and preventing drug-related problems was conducted to evaluate improvement in the efficiency of resource utilization.


Pamala A. Pawloski, PharmD

Latest:

Barriers to and Facilitators of Medication Adherence

This study reports on barriers to and facilitators of medication adherence for asthma and diabetes patients who were both adherent and nonadherent to their medication regimen.


Blair Green Thielemier, PharmD

Latest:

Could Preemptive Pharmacogenomic Testing Emerge as an MTM Best Practice?

Pharmacists and physicians can now use pharmacogenomic test results to help choose safer and more effective medications for their patients.